Skip to main content

Clozapine & Adherence to Absolute Neutrophil Count (ANC) Monitoring and Neutropenia

Basic Details
Status
Ongoing
Last Updated
Tuesday, December 3, 2024
Original Posting Date
Health Outcome(s)
adherence to absolute neutrophil count (ANC) monitoring
neutropenia
Purpose
Drug and Outcome Analysis
Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR
No
Result(s) (7)
Clozapine Use: First Descriptive Analysis Clozapine Use: Second Descriptive Analysis Adherence to Absolute Neutrophil Count (ANC) Monitoring Recommendations Following Clozapine Use: First Descriptive Analysis Adherence to Absolute Neutrophil Count (ANC) Monitoring Recommendations Following Clozapine Use: Second Descriptive Analysis Adherence to Absolute Neutrophil Count (ANC) Monitoring Recommendations Following Clozapine Use: Third Descriptive Analysis Occurrence of Absolute Neutrophil Count (ANC) Monitoring, ANC Laboratory Results, and Neutropenia Following Clozapine Use: A Descriptive Analysis Occurrence of Absolute Neutrophil Count (ANC) Monitoring and Neutropenia Following Clozapine Use in Patients from Sentinel Data Partners that Curate ANC Laboratory Results: A Descriptive Analysis
Regulatory Link(s) (1)
Joint Meeting of the Drug Safety and Risk Management Advisory Committee and Psychopharmacologic Drugs Advisory Committee Meeting